Literature DB >> 10716674

Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man.

J Tack1, B Coulie, A Wilmer, A Andrioli, J Janssens.   

Abstract

BACKGROUND: In animals, activation of 5-HT(1) like receptors causes a relaxation of the gastric fundus through the activation of intrinsic inhibitory neurones. AIMS: To investigate the effect of sumatriptan, an agonist at enteric neuronal 5-HT(1) receptors, on fasting fundus tone and sensitivity to gastric distension in man.
METHODS: A gastric barostat was used to study the effect of placebo and sumatriptan, 6 mg subcutaneously, on basal fundic tone in healthy subjects. In addition, stepwise isobaric and isovolumetric gastric distensions were performed and perception was measured before and after the administration of placebo and sumatriptan.
RESULTS: Placebo had no significant effects on gastric tone and on perception. Sumatriptan induced an immediate relaxation of the gastric fundus, reflected by an intragastric volume increase of 209 (39) ml (p<0.0005). After sumatriptan, intragastric pressures at the thresholds for perception or discomfort were not significantly altered. However, the intragastric volumes and the corresponding calculated wall tensions at perception and discomfort thresholds were significantly increased.
CONCLUSIONS: Administration of the 5-HT(1) receptor agonist sumatriptan induces a relaxation of the gastric fundus in man, allowing larger intragastric volumes before thresholds for perception or discomfort are reached. The effects of sumatriptan on the gastric fundus may have therapeutic potential in the treatment of patients with functional dyspepsia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716674      PMCID: PMC1727890          DOI: 10.1136/gut.46.4.468

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Gastric wall tension determines perception of gastric distention.

Authors:  E Distrutti; F Azpiroz; A Soldevilla; J R Malagelada
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

2.  Actions of 5-hydroxytryptamine on myenteric neurons in guinea pig gastric antrum.

Authors:  J F Tack; J Janssens; G Vantrappen; J D Wood
Journal:  Am J Physiol       Date:  1992-12

Review 3.  Biomechanics of the gastrointestinal tract.

Authors:  H Gregersen; G Kassab
Journal:  Neurogastroenterol Motil       Date:  1996-12       Impact factor: 3.598

4.  Subpopulations of gastric myenteric neurons are differentially activated via distinct serotonin receptors: projection, neurochemical coding, and functional implications.

Authors:  K Michel; H Sann; C Schaaf; M Schemann
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

5.  Gastric tone determines the sensitivity of the stomach to distention.

Authors:  R Notivol; B Coffin; F Azpiroz; F Mearin; J Serra; J R Malagelada
Journal:  Gastroenterology       Date:  1995-02       Impact factor: 22.682

Review 6.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

Review 7.  Basic and clinical aspects of visceral hyperalgesia.

Authors:  E A Mayer; G F Gebhart
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

8.  Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia.

Authors:  B Coffin; F Azpiroz; F Guarner; J R Malagelada
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

9.  Alosetron does not affect the visceral perception of gastric distension in healthy subjects.

Authors:  F Zerbib; S Bruley des Varannes; R C Oriola; J McDonald; J P Isal; J P Galmiche
Journal:  Aliment Pharmacol Ther       Date:  1994-08       Impact factor: 8.171

10.  Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy.

Authors:  L E Troncon; D G Thompson; N K Ahluwalia; J Barlow; L Heggie
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

View more
  59 in total

1.  Lump or split dyspepsia? A continuing controversy.

Authors:  N J Talley; S Thitiphuree
Journal:  Curr Gastroenterol Rep       Date:  2001-06

2.  Smooth muscle 5-HT2A receptors mediating contraction of porcine isolated proximal stomach strips.

Authors:  P Janssen; N H Prins; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Functional Dyspepsia: Impaired Fundic Accommodation.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

4.  Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

Authors:  Fabrizio De Ponti; Francesca Crema
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

Review 5.  Serotonergic modulating drugs for functional gastrointestinal diseases.

Authors:  Robin Spiller
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

6.  Of actors, bolting horses, and drops in oceans!

Authors:  F Cremonini; M Camilleri
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

7.  Functional Dyspepsia: A New Rome III Paradigm.

Authors:  Smita L S Halder; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

8.  Advances in the management of gastroparesis.

Authors:  Frank K Friedenberg; Henry P Parkman
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

9.  Electroacupuncture restores impaired gastric accommodation in vagotomized dogs.

Authors:  Hui Ouyang; Jinhong Xing; Jdz Chen
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

10.  In vivo characterization of 5-HT1A receptor-mediated gastric relaxation in conscious dogs.

Authors:  P Janssen; N H Prins; B Moreaux; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.